Gulcin Gezgin
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Tumour progression shows decrease in PD-L1 expression in matched metastases/primary uveal melanomas.
Tumour progression shows decrease in PD-L1 expression in matched metastases/primary uveal melanomas.
Journal: Acta ophthalmologica
Published: December 30, 2024
PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma.
Journal: Investigative ophthalmology & visual science
Published: December 27, 2023
Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment.
Journal: Ophthalmology science
Published: August 19, 2021
Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution.
Journal: Cancers
Published: May 29, 2019
PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Journal: JAMA ophthalmology
Published: April 28, 2017
GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi.
Journal: British journal of cancer
Published: April 21, 2017
Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment.
Journal: Cancer immunology, immunotherapy : CII
Published: September 05, 2016
PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 03, 2016
EMT-associated factors promote invasive properties of uveal melanoma cells.
Journal: Molecular vision
Published: April 06, 2015
Reply to letter to the editor by Koza et al.
Journal: American heart journal
Published: November 02, 2013
Last Updated: 09/26/2026